Loading...

A meta-analysis of the comparing of the first-generation and next-generation TKIs in the treatment of NSCLC

BackgroundThe current standard approach to the treatment of patients with non-small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)—sensitizing mutations has been the treatment with a first-generation EGFR-TKIs. While, with resistance develope...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Yongxing Li, Jianye Yang, Yufen Xu, Ming Zhang, Xiaoping Zhang, Wenyu Chen, Xiaodong Lv
Format: Artigo
Sprog:Inglês
Udgivet: AIMS Press 2019-06-01
Serier:Mathematical Biosciences and Engineering
Fag:
Online adgang:https://www.aimspress.com/article/10.3934/mbe.2019283?viewType=HTML
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!